↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Träfflista för sökning "WFRF:(Ullén Magnus) "

Search: WFRF:(Ullén Magnus)

Result 1-10 of 151

Sort/group result

Sort by: Hits per page:

Enumeration	Reference	Cover	Find
1.	Ullén, Petrus (author) Disputationis philosophicæ, de insufficientia religionis naturalis, partem priorem, ... præside ... Mag. Petro Ullén, ... publico examini modeste subjicit stipendiarius regius Ericus Magnus Hiortzberg Nericius. In Auditorio Carol. Majori, ad diem XXVI. Febr. Anno MDCCXLVI. Horis, ante meridiem, consuetis., p. 1 1746 Doctoral thesis (other academic/artistic)
2.	Ullén, Petrus (author) Dissertatio gradualis de extensione cognitionis humanæ per propositiones universales; cujus partem posteriorem, cum consensu ampliss. facult. philof. in reg. Acad. Upsal. Præside adm. rever. & celeberrimo viro, mag. Petro Ullén, log. & metaph. profess. reg. & ord. Ad publicum eruditorum examen modeste defert. Alumnus regius, Magnus Fallerstedt, O-Gothos. In aud. car. min. d. 15 Junii. A. 1743. 1743 Doctoral thesis (other academic/artistic)
3.	Ullén, Petrus (author) Dissertatio philosophica de bonitate metaphysica; quam ... præside ... Mag. Petro Ullén ... publicæ eruditorum censuræ modeste subjicit stipendiarius Sollenianus, Magnus Granlund, Angermannus. In Auditor. Carol. Maj. ad d. 17. Dec. Anni MDCCXLIII. Horis, ante meridiem, solitis. 1743 Doctoral thesis (other academic/artistic)
4.	Ullén, Petrus (author) Exercitium academicum de experientia; quod, ... præside viro celeberrimo, Mag. Petro Ullén, ... publico bonorum examini submittit Petrus Magni Klockhoff, Medelpadus. In Audit. Gustav. Major. d. 14. Junii, An. MDCC XXXIX. Horis, a. m., solitis. 1739 Doctoral thesis (other academic/artistic)
5.	Ullén, Petrus (author) Exercitium academicum, de extensione cognitionis humanæ per propositiones universales; cujus partem priorem, ... præside ... Mag. Petro Ullén, ... ad publicum eruditorum examen modeste defert alumnus regius, Magnus Fallerstedt, O. Gothus. In Audit. Car. Maj. d. 3. Maji, A. 1743. Horis, ante meridiem, solitis., p. 1 1742 Doctoral thesis (other academic/artistic)
6.	Ullén, Petrus (author) Exercitium academicum de habitu; quod ... præside, viro celeberrimo Mag. Petro Ullén, ... publico examini subjicit Magnus Walltier, Westro-Botniensis, In Audit. Gustav. Maj. d. 10. Mart. Anni MDCCXXXIX. Horis, ante meridiem, solitis. 1739 Doctoral thesis (other academic/artistic)
7.	Ullén, Petrus (author) Exercitium academicum de propositione categorica et hypothetica; quod; ... præside viro celeberrimo, Mag. Petro Ullén, ... Ad publicum Examen modeste defert Olavus Friberg, Wermelandus. In Audit. Gust. Major. d. 10. Novemb. Anni MDCCXXXIX. Horis ante meridiem solitis. 1739 Doctoral thesis (other academic/artistic)
8.	Ullén, Petrus (author) Quæstio philosophica, an veritas objectioni insolubili obnoxia esse possit? Quam ... præside ... mag. Petro Ullén ... publico bonorum examini modeste submittit ... Magnus Söderborg, westro-gothus. In audit. Carol. majori die [16] septemb. anni MDCCXLII. 1742 Doctoral thesis (other academic/artistic)
9.	Berglund, Åke, et al. (author) First-in-human, phase I/IIa clinical study of the peptidase potentiated alkylator melflufen administered every three weeks to patients with advanced solid tumor malignancies 2015 In: Investigational new drugs. - : Springer Science and Business Media LLC. - 0167-6997 .- 1573-0646. ; 33:6, s. 1232-1241 Journal article (peer-reviewed)abstract Purpose Melflufen (melphalan flufenamide, previously designated J1) is an optimized and targeted derivative of melphalan, hydrolyzed by aminopeptidases overexpressed in tumor cells resulting in selective release and trapping of melphalan, and enhanced activity in preclinical models. Methods This was a prospective, single-armed, open-label, first-in-human, dose-finding phase I/IIa study in 45 adult patients with advanced and progressive solid tumors without standard treatment options. Most common tumor types were ovarian carcinoma (n = 20) and non-small-cell lung cancer (NSCLC, n = 11). Results In the dose-escalating phase I part of the study, seven patients were treated with increasing fixed doses of melflufen (25-130 mg) Q3W. In the subsequent phase IIa part, 38 patients received in total 115 cycles of therapy at doses of 30-75 mg. No dose-limiting toxicities (DLTs) were observed at 25 and 50 mg; at higher doses DLTs were reversible neutropenias and thrombocytopenias, particularly evident in heavily pretreated patients, and the recommended phase II dose (RPTD) was set to 50 mg. Response Evaluation Criteria In Solid Tumors (RECIST) evaluation after 3 cycles of therapy (27 patients) showed partial response in one (ovarian cancer), and stable disease in 18 patients. One NSCLC patient received nine cycles of melflufen and progressed after 7 months of therapy. Conclusions In conclusion, melflufen can safely be given to cancer patients, and the toxicity profile was as expected for alkylating agents; RPTD is 50 mg Q3W. Reversible and manageable bone marrow suppression was identified as a DLT. Clinical activity is suggested in ovarian cancer, but modest activity in treatment of refractory NSCLC.
10.	Blennow Nordström, Erik, et al. (author) EVALUATION OF A NEUROCOGNITIVE SCREENING FOR OUT-OF-HOSPITAL CARDIAC ARREST SURVIVORS 2024 In: Journal of the American College of Cardiology. - 1558-3597. ; 83:13, Supplement, s. 1198-1198 Conference paper (peer-reviewed)

Skapa referenser, mejla, bekava och länka

Permalink

Result 1-10 of 151

Refine your search

Type of publication: journal article (58); conference paper (37); book chapter (15); doctoral thesis (14); review (12); other publication (5); show more...; book (4); editorial collection (3); editorial proceedings (2); licentiate thesis (1); show less...

Type of content: peer-reviewed (81); other academic/artistic (47); pop. science, debate, etc. (23)

Author/Editor: Ullén, Susann (11); Ullén, Petrus (9); Cronberg, Tobias (6); Nielsen, Niklas (6); Friberg, Hans (6); Lilja, Gisela (6); show more...; Heimburg, Katarina (6); Blennow Nordström, E ... (6); Mion, Marco (6); Segerström, Magnus (6); Grejs, Anders M. (6); Johannesson, Magnus (5); Undén, Johan (5); Nilsson, Maria H. (5); Rylander, Christian (5); Kirkegaard, Hans (5); Wise, Matthew P. (5); Ullén, Fredrik (5); Cesarini, David (4); Vestberg, Susanna (4); Evald, Lars (4); Madison, Guy (3); Johansson, Christer (3); Johansson, Anders (3); Dahlberg, Leif (3); Mattsson-Carlgren, N ... (3); Möller, Håkan (3); Forslid, Torbjörn (3); Sjöholm, Cecilia (3); Bergman, Kerstin (3); Helgesson, Stefan (3); Keeble, Thomas (3); Keeble, Thomas R. (3); Ljung, Hanna (3); Rose, Sofia (3); Sundén, Jenny (3); Björklund, Jenny, 19 ... (2); Pedersen, Nancy (2); Hansson, Oskar (2); Stomrud, Erik (2); Magnusson, Patrik K ... (2); Pedersen, Nancy L (2); Palmqvist, Sebastian (2); Franzén, Carin (2); Bro-Jeppesen, John (2); Mattsson, Niklas (2); Magnusson, Patrik (2); Pirholt, Mattias, 19 ... (2); Lönngren, Ann-Sofie, ... (2); Gregersen Oestergaar ... (2); show less...

University: Karlstad University (97); Uppsala University (34); Stockholm University (12); Lund University (12); Karolinska Institutet (5); Umeå University (4); show more...; Örebro University (3); Stockholm School of Economics (3); University of Gothenburg (2); Södertörn University (2); Linnaeus University (1); show less...

Language: English (89); Swedish (53); Latin (9)

Research subject (UKÄ/SCB): Humanities (127); Medical and Health Sciences (14); Social Sciences (13); Natural sciences (2)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - National Library Systems
LIBRIS.kb.se

pil uppåt

Close

Copy and save the link in order to return to this view